Mr. Speaker, when we think of medications, it is important that we recognize that there are benefits versus risks. I would think that one of the greatest challenges that we have within government is the education about those benefits and risks.
A part of education means that we have to understand where we have issues with certain drugs when the risks are too high. There is this lack of information flow that supports Health Canada and other organizations to be able to educate the user. This is something that is critically important. I say that, because when I look at this legislation, what the Liberal Party and I see is legislation that at least moves us in the right direction. The Liberal Party's health critic has spoken on this legislation and indicated that we would like to see the bill go to committee. We are even prepared to see the bill go today.
My question for the member is, if the NDP is not in a position to pass this today, does he believe that they would like to get the bill called again? If so, when would they like to see it called again?